Filing Details
- Accession Number:
- 0000310764-21-000156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-14 18:44:19
- Reporting Period:
- 2021-12-10
- Accepted Time:
- 2021-12-14 18:44:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310764 | Stryker Corp | SYK | Surgical & Medical Instruments & Apparatus (3841) | 381239739 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670936 | S Glenn Boehnlein | 2825 Airview Blvd Kalamazoo MI 49002 | Vp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-10 | 447 | $258.98 | 15,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 1,757 | $259.68 | 13,679 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 574 | $260.78 | 13,105 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,435 | Indirect | By 401K |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2021.
- This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $258.88 to $259.07, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
- This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $259.21 to $260.13, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
- This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $260.67 to $261.37, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4).
Billionaire Hedge Funds
